“Global Bioprocess Optimisation & Digital Biomanufacturing market is expected to reach $68.9bn by 2029” says new Visiongain report

28 February 2020
Pharma

Visiongain has launched a new pharma report Global Bioprocess Optimisation & Digital Biomanufacturing Market Forecast.

The Global market for bioprocess optimisation and digital biomanufacturing is favoured by the increasing global population which by 2050 will be predominately 65 years and above. There is also a growing demand for biologics drugs and biosimilar drugs which has compelled manufacturers to introduce technologies that would help bring the drugs to the market at a far more rapid pace than before.

The lead analyst of the report commented "The Bioprocess Optimization and Digital Manufacturing market is expected to witness a robust growth during the years of forecast owing to rise in biosimilars, growing complexity of drug manufacturing and patent expiry of blockbuster drugs coupled with rising cost containment pressure on biopharmaceutical players which is also expected to improve the uptake of digitally advanced products for manufacturing. With respect to the technology market, the analytical and process control technologies are expected to witness the highest growth during the forecast period. The bioreactors market is expected to foresee the highest growth during the forecast period."

Leading companies featured in the report include ABB, 3M Co., Danaher Corporation, Agilent Technologies, Applikon Technology, Sartorius Stedium Biotech, Shimadzu Corp., Siemens Healthcare and many others.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Nasal Drug Delivery Technology Market Report 2022-2032

The nasal drug delivery market will expand rapidly due to rising patient preference for nasal medication delivery due to ease of administration and efficacy, increased self-administration practises, and increased demand for home healthcare equipment.

18 January 2022

Read

Visiongain Publishes Deep Frozen Packaging Logistics Market Report 2022-2032

The desire for various types of medications to assist combat a growing number of chronic diseases & lifestyle-related ailments is fuelling the overall deep freeze packaging logistics market demand.

14 January 2022

Read

Visiongain Publishes Pre-Filled Syringes Market Report 2022-2032

With COVID-19 pandemic, the prefilled syringes business has witnessed a significant growth. Since the outbreak of the pandemic, global market players involved in the development of the prefilled syringes market across the globe have increased their investment in raw materials and resources owing to the rise in demand for home based healthcare services.

11 January 2022

Read

Visiongain Publishes Single-use Bioprocessing Probes & Sensors Market Report 2022-2032

To promote their organic revenue growth and market presence, the top companies are pursuing different strategic initiatives such as OEM collaborations and new product development with better technological intricacy.

05 January 2022

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever